BSE filing, NSE: KSR. Summary written from the filing by ALFA Finder's alert engine.
KSR Footwear Ltd: key numbers
- Share price
- ₹34.50
- Market cap
- ₹63.41 Cr
- Revenue (annual)
- ₹199.9 Cr
- Net profit (annual)
- ₹-12.74 Cr
- P/E (TTM)
- -8.3×Sector 62.0×
- Promoter holding
- 60.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KSR Footwear Ltd
All →KSR Footwear Credit Rating
India Ratings upgraded KSR Footwear's bank loan long-term rating to IND BB+/Stable, affirming short-term at IND A4+. The rated facility totals ₹360 Million.
KSR Footwear Annual General Meeting
KSR Footwear held its 3rd Annual General Meeting on August 24, 2026. Shareholders approved all ordinary resolutions presented during the proceedings.
KSR Footwear Results Correction
KSR Footwear Limited submitted high-resolution, machine-readable financial results for Q1 FY27. This filing responds to an NSE query regarding the legibility of previous submissions.
KSR Footwear Management Change
KSR Footwear Limited has appointed Mr. Vikram Jeet Sharma as Chief Financial Officer, effective August 5, 2026. This change follows the company's recent board meeting.
KSR Footwear Q1 FY27 Results: Turns Profitable, Net Profit ₹0.3 Cr
KSR Footwear Ltd reported revenue from operations of ₹52.2 Cr (+0.2% YoY) and net profit of ₹0.3 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr
KSR Footwear Other Announcement
KSR Footwear Limited informs shareholders about the availability of its Annual Report and Notice of the 3rd AGM via a weblink, pursuant to SEBI regulations.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.